Table 2: Prevalence of comorbidities at the time of initiation of the hemodialysis therapy and the educational level.

Signs and Symptoms ≤ 4* (%)
(n= 157)
>4* (%)
(n= 57)
Total (%)
(n=214)
p&
Hypertension 138 (87.90) 51 (89.47) 189 (88.32) 0.82
Diabetes Mellitus 62 (39.49) 25 (43.86) 87 (40.65) 0.64
Diabeticneuropathy 43 (27.39) 15 (26.32) 58 (27.10) 1.00
Chronic Kidney Disease - Mineral and Bone Disorder 34 (21.66) 14 (24.56) 48 (22.43) 0.71
Diabetic retinopathy 29 (18.47) 14 (24.56) 43 (20.09) 0.34
Dyslipidemia 27 (17.20) 10 (17.54) 37 (17.29) 1.00
Peripheral arterial disease 23 (14.65) 13 (22.81) 36 (16.82) 0.21
Stroke 21 (13.38) 8 (14.04) 29 (13.55) 1.00
Osteoporosis 18 (11.46) 8 (14.04) 26 (12.15) 0.64
Myocardial infarction 14 (8.92) 9 (15.79) 23 (10.75) 0.21
Heart failure 14 (8.92) 9 (15.79) 23 (10.75) 0.21
Diabetic feet 16 (10.19) 6 (10.53) 22 (10.28) 1.00
Angina pectoris 14 (8.92) 4 (7.02) 18 (8.41) 0.79
Amputation 11 (7.01) 5 (8.77) 16 (7.48) 0.77
Epigastric pain 8 (5.10) 2 (3.51) 10 (4.67) 0.73
Hepatitis B virus infection 4 (2.55) 2 (3.51) 6 (2.80) 1.00
Hepatitis C virus infection 3 (1.91) 2 (3.51) 5 (2.34) 0.61
HIV infection 1 (0.64) 1 (1.75) 2 (0.93) 1.00

* Years of formal education.
& The Chi-square test was used to compare the frequencies of each event. The level of significance was set at p < 0.05.